Top compounds associated with response to RNLS


Feature Type Standardized
Nominal ANOVA
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC -0.15 5e-07
mRNA FK866 GDSC1000 pan-cancer AAC -0.14 2e-06
mRNA GSK1070916 GDSC1000 pan-cancer AAC -0.14 4e-06
mRNA Methotrexate GDSC1000 pan-cancer AAC -0.13 6e-06
mRNA CAY10618 CTRPv2 pan-cancer AAC -0.16 9e-06
mRNA alisertib CTRPv2 pan-cancer AAC -0.14 1e-05
mRNA BRD1812 CTRPv2 pan-cancer AAC -0.16 1e-05
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 2e-05
mRNA QL-XI-92 GDSC1000 pan-cancer AAC -0.13 2e-05
mRNA Doxorubicin CTRPv2 pan-cancer AAC -0.13 3e-05
Download CSV